Skip to main page content
U.S. flag
See More

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2025 Sep 26;26(1):362.
doi: 10.1186/s13063-025-09094-0.

Effect of dexmedetomidine on perioperative blood glucose regulation in type 2 diabetic patients undergoing laparoscopic colorectal cancer radical resection: a randomised double-blinded controlled trial

Wei Dai #  1 , Jinlong Zhou #  2 , Lunjing Qu  3 , Kaihua He  4
Affiliations
Randomized Controlled Trial

Effect of dexmedetomidine on perioperative blood glucose regulation in type 2 diabetic patients undergoing laparoscopic colorectal cancer radical resection: a randomised double-blinded controlled trial

Wei Dai et al. Trials. .

Abstract

Background: The stability of blood glucose levels in diabetic patients is more susceptible to fluctuations than in nondiabetic individuals. The effect of dexmedetomidine on glucose fluctuations in diabetic patients remains unclear. This study aimed to investigate the effect of intraoperative dexmedetomidine on glucose homeostasis in patients with type 2 diabetes undergoing laparoscopic colorectal cancer radical resection.

Methods: 80 participants with T2DM preparing for laparoscopic colorectal cancer radical resection were randomly divided into four groups: control group (group C), dexmedetomidine 1 μg ⋅ kg-1 + 0.25 μg ⋅ kg-1 ⋅ h-1 (group D1), 1 μg ⋅ kg-1 + 0.5 μg ⋅ kg-1 ⋅ h-1 (group D2), and 1 μg ⋅ kg-1 + 0.75 μg ⋅ kg-1 ⋅ h-1 (group D3). Levels of blood glucose were measured before the intravenous infusion of dexmedetomidine (T1), 15 min after the intubation(T2), 1 h after the beginning of the surgery (T3), at the end of the surgery (T4), and 30 min after the extubation in PACU (T5).

Results: Compared with the baseline levels, the levels of blood glucose from T2 to T5 in group C increased gradually but were not significantly different at each time point (p > 0.05), and there was a statistically significant rise in blood glucose in group D1 at T3, T4, and T5 and in groups D2 and D3 at T2, T3, and T4 (p < 0.05). Compared with group C, blood glucose in groups D2 and D3 was significantly higher at T3, andT4 (p < 0.05). Compared with group C, the rangeability from T1 to T3 and T1 to T4 was significantly higher in groups D2 and D3 (p < 0.05).

Conclusion: Dexmedetomidine loading dose 1 μg/kg and a Maintenance dose 0.25 μg/kg/h can be used in type 2 diabetic patients for better glucose regulation without increasing the incidence of perioperative hyperglycemia, adverse effects, and extending extubation time.

Trial registration: ChiCTR2100042050. Registered on January 13, 2021, with ChiCTR. https://www.chictr.org.cn/showproj.html?proj=120133 .

Keywords: Colorectal cancer; Dexmedetomidine; Diabetics; Perioperative blood glucose.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: This study was conducted in accordance with the Declaration of Helsinki and followed the guidelines of Consolidated Standards of Reporting Trials (CONSORT). Ethics approval was obtained from the ethics committee of the First Affiliated Hospital of Chongqing Medical University, Chongqing, China (approval number: 2020–406), approval date: 26 July 2021). Letters of informed consent signed by patients were obtained. The trial was registered at the Chinese Clinical Trial Registry (registration number: ChiCTR2100042050, registration date: 2021 January 13). Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
The consort flow chart
Fig. 2
Fig. 2
Comparison of the required dose for anaesthetics and extubation time. ap < 0.05 compared with group C. bp < 0.05 compared with group D1
See this image and copyright information in PMC

References

    1. Cheisson G, Jacqueminet S, Cosson E, Ichai C, Leguerrier AM, Nicolescu-Catargi B, et al. Perioperative management of adult diabetic patients. Intraoperative period. Anaesth Crit Care Pain Med 2018;37 Suppl 1:S21-s5. - PubMed
    1. Nair BG, Neradilek MB, Newman SF, Horibe M. Association between acute phase perioperative glucose parameters and postoperative outcomes in diabetic and non-diabetic patients undergoing non-cardiac surgery. Am J Surg. 2019;218(2):302–10. - PubMed
    1. Shanks AM, Woodrum DT, Kumar SS, Campbell DA Jr, Kheterpal S. Intraoperative hyperglycemia is independently associated with infectious complications after non-cardiac surgery. BMC Anesthesiol. 2018;18(1):90. - PMC - PubMed
    1. Hsieh CJ. High glucose variability increases 30-day readmission rates in patients with type 2 diabetes hospitalized in department of surgery. Sci Rep. 2019;9(1):14240. - PMC - PubMed
    1. Windmann V, Spies C, Knaak C, Wollersheim T, Piper SK, Vorderwülbecke G, et al. Intraoperative hyperglycemia increases the incidence of postoperative delirium. Minerva Anestesiol. 2019;85(11):1201–10. - PubMed

Publication types

MeSH terms

LinkOut - more resources